Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials.

Kasenda B, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Ebrahim S, Schandelmaier S, Sun X, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M.

PLoS Med. 2016 Jun 28;13(6):e1002046. doi: 10.1371/journal.pmed.1002046. eCollection 2016 Jun.

3.

Characterisation of trials where marketing purposes have been influential in study design: a descriptive study.

Barbour V, Burch D, Godlee F, Heneghan C, Lehman R, Perera R, Ross JS, Schroter S.

Trials. 2016 Jan 21;17:31. doi: 10.1186/s13063-015-1107-1.

4.

Because of Science You Also Die... Comment on "Quaternary Prevention, an Answer of Family Doctors to Over Medicalization".

Bernstein J, Valle RL.

Int J Health Policy Manag. 2015 May 20;4(9):615-6. doi: 10.15171/ijhpm.2015.102.

5.
6.
7.
8.

Industry actors, think tanks, and alcohol policy in the United kingdom.

Hawkins B, McCambridge J.

Am J Public Health. 2014 Aug;104(8):1363-9. doi: 10.2105/AJPH.2013.301858. Epub 2014 Jun 12. Erratum in: Am J Public Health. 2015 Feb;105(2):e5.

9.

Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications.

Maund E, Tendal B, Hróbjartsson A, Jørgensen KJ, Lundh A, Schroll J, Gøtzsche PC.

BMJ. 2014 Jun 4;348:g3510. doi: 10.1136/bmj.g3510. Review.

10.
11.

Conflicts of interest in biomedical publications: considerations for authors, peer reviewers, and editors.

Gasparyan AY, Ayvazyan L, Akazhanov NA, Kitas GD.

Croat Med J. 2013 Dec;54(6):600-8. Review.

12.

Poor health in rich countries: a role for open access journals.

PLOS Medicine Editors.

PLoS Med. 2013 Oct;10(10):e1001543. doi: 10.1371/journal.pmed.1001543. Epub 2013 Oct 29.

13.

Taking financial relationships into account when assessing research.

Resnik DB, Elliott KC.

Account Res. 2013;20(3):184-205. doi: 10.1080/08989621.2013.788383.

14.

Human gut microbiota: repertoire and variations.

Lagier JC, Million M, Hugon P, Armougom F, Raoult D.

Front Cell Infect Microbiol. 2012 Nov 2;2:136. doi: 10.3389/fcimb.2012.00136. eCollection 2012. Review.

15.

High reprint orders in medical journals and pharmaceutical industry funding: case-control study.

Handel AE, Patel SV, Pakpoor J, Ebers GC, Goldacre B, Ramagopalan SV.

BMJ. 2012 Jun 28;344:e4212. doi: 10.1136/bmj.e4212.

16.

Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.

Alfonso F, Timmis A, Pinto FJ, Ambrosio G, Ector H, Kulakowski P, Vardas P; Editors’ Network European Society of Cardiology Task Force.

Neth Heart J. 2012 Jun;20(6):279-87. doi: 10.1007/s12471-012-0277-7.

17.

The imperative to share clinical study reports: recommendations from the Tamiflu experience.

Doshi P, Jefferson T, Del Mar C.

PLoS Med. 2012;9(4):e1001201. doi: 10.1371/journal.pmed.1001201. Epub 2012 Apr 10. No abstract available.

19.

Comparative effectiveness research: an empirical study of trials registered in ClinicalTrials.gov.

Bourgeois FT, Murthy S, Mandl KD.

PLoS One. 2012;7(1):e28820. doi: 10.1371/journal.pone.0028820. Epub 2012 Jan 9.

20.

Pediatric bipolar disorder in an era of "mindless psychiatry".

Parry PI, Levin EC.

J Trauma Dissociation. 2012;13(1):51-68. doi: 10.1080/15299732.2011.597826. Review.

Items per page

Supplemental Content

Write to the Help Desk